Clarithromycin and Ocrevus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clarithromycin (clarithromycin) and Ocrevus (ocrelizumab). Common drug interactions include ill-defined disorder among females and elbow deformity among males.

The phase IV clinical study analyzes what interactions people have when they take Clarithromycin and Ocrevus. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Clarithromycin?

Clarithromycin has active ingredients of clarithromycin. It is often used in sinusitis. eHealthMe is studying from 45,044 Clarithromycin users. Check the latest studies of Clarithromycin.

What is Ocrevus?

Ocrevus has active ingredients of ocrelizumab. eHealthMe is studying from 56,583 Ocrevus users. Check the latest studies of Ocrevus.

On Jul, 11, 2026

27 people who take Clarithromycin and Ocrevus together, and have interactions are studied.

Clarithromycin and Ocrevus drug interactions.

What are the common drug interactions of Clarithromycin and Ocrevus, by gender? *:

female:

Ill-defined disorder
Muscle spasticity (tight or stiff muscles and an inability to control those muscles)
Neutropenia (an abnormally low number of neutrophils)
Fatigue (feeling of tiredness)
Nasopharyngitis (inflammation of the nasopharynx)
Nausea (feeling of having an urge to vomit)
Oropharyngeal pain
Weight increased
Headache (pain in head)
Pyrexia (fever)

male:

Elbow deformity
Drug ineffective
Blood immunoglobulin g decreased
Blood immunoglobulin m decreased
Localised infection (infection at the single location)
Rhinorrhoea (watery mucus discharge from the nose)
Upper respiratory tract infection
Chills (felling of cold)
Fatigue (feeling of tiredness)
Feeling cold

What are the common drug interactions of Clarithromycin and Ocrevus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Parosmia (distortion of the sense of smell, as in smelling odours that are not present)
Skin burning sensation
Tooth fracture
Vomiting
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Neutropenia (an abnormally low number of neutrophils)
Fatigue (feeling of tiredness)
Nasopharyngitis (inflammation of the nasopharynx)
Nausea (feeling of having an urge to vomit)
Oropharyngeal pain

40-49:

Fatigue (feeling of tiredness)
Feeling cold
Gait disturbance
Haematoma (collection of blood outside the blood vessels)
Mood swings (an extreme or rapid change in mood)
Respiratory syncytial virus infection (viral disease of respiratory system)
Chest discomfort
Dyspnoea (difficult or laboured respiration)
Pain in extremity
Nasopharyngitis (inflammation of the nasopharynx)

50-59:

n/a

60+:

Asthenia (weakness)
Atypical pneumonia (acute respiratory disease marked by high fever and coughing)
Cough
Localised infection (infection at the single location)
Pyrexia (fever)
Rales (an abnormal respiratory sound characterized by fine crackles)

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 17 people, 62.96%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 14.81%
Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 11.11%
Depression: 3 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Clarithromycin and Ocrevus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously